Genomate and VivaMed to Rescue and Repurpose Oncology Drugs with AI and Clinical Data
Genomate Health, a precision oncology company, today announced a strategic partnership with VivaMed BioPharma to advance existing drugs and promising compounds for new applications in cancer based on the underlying molecular interactions of the tumor. Together, they aim to build the computational and clinical evidence needed to bring these treatments to market for the patients most likely to benefit. Progress in cancer treatment remains uneven....
Read more








